John Edward Adent
Net Worth

Last updated:

What is John Edward Adent net worth?

The estimated net worth of Mr. John Edward Adent is at least $11,283,740 as of 28 Oct 2024. He owns shares worth $1,214,436 as insider, has earned $4,158,294 from insider trading and has received compensation worth at least $5,911,010 in Neogen Corporation.

What is the salary of John Edward Adent?

Mr. John Edward Adent salary is $844,430 per year as Pres, Chief Executive Officer & Director in Neogen Corporation.

How old is John Edward Adent?

Mr. John Edward Adent is 57 years old, born in 1968.

What stocks does John Edward Adent currently own?

As insider, Mr. John Edward Adent owns shares in one company:

Company Title Shares Price per share Total value
Neogen Corporation (NEOG) Pres, Chief Executive Officer & Director 216,477 $5.61 $1,214,436

What does Neogen Corporation do?

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

John Edward Adent insider trading

Neogen Corporation

Mr. John Edward Adent has made 3 insider trades between 2018-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 698,251 units of NEOG stock on 26 Oct 2023. As of 28 Oct 2024 he still owns at least 216,477 units of NEOG stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 38,760 $13.81 $535,276
Option
Common Stock 38,760 $13.81 $535,276
Option
Restricted Stock Units 3,064 $14.43 $44,214
Option
Common Stock 3,064 $14.43 $44,214
Purchase
Common Stock 14,500 $13.8 $200,100
Option
Restricted Stock Units 32,937 $15.07 $496,361
Option
Common Stock 32,937 $15.07 $496,361
Option
Restricted Stock Units 116,279 $15.48 $1,799,999
Option
Common Stock (Right to Buy) 698,251 $15.48 $10,808,925
Option
Restricted Stock Units 90,361 $13.28 $1,199,994
Option
Common Stock (Right to Buy) 625,001 $13.28 $8,300,013
Purchase
Common Stock 22,000 $14.37 $316,140
Purchase
Common Stock 17,500 $23.07 $403,725
Option
Common Stock (Right to Buy) 85,890 $28.4 $2,439,276
Option
Restricted Stock Units 10,563 $28.4 $299,989
Option
Restricted Stock Units 15,317 $40.85 $625,699
Option
Common Stock (Right to Buy) 150,352 $9.71 $1,459,918
Sale
Common Stock 40,464 $87.99 $3,560,387
Option
Common Stock (Right to Buy) 40,464 $63.3 $2,561,371
Option
Common Stock 40,464 $63.3 $2,561,371
Option
Common Stock 13,536 $63.1 $854,122
Option
Common Stock 13,536 $63.1 $854,122
Option
Common Stock (Right to Buy) 13,536 $63.1 $854,122
Option
Common Stock (Right to Buy) 13,536 $63.1 $854,122
Sale
Common Stock 9,536 $62.7 $597,907
Option
Common Stock 40,000 $51.29 $2,051,720
Option
Common Stock 40,000 $51.29 $2,051,720
Option
Common Stock (Right to Buy) 20,000 $51.29 $1,025,860
Option
Common Stock (Right to Buy) 76,877 $68.3 $5,250,699
Option
Restricted Stock Unit 7,040 N/A N/A
Purchase
Common Stock 1,750 N/A N/A
Purchase
Common Stock 1,517 N/A N/A
Option
Common Stock (Right to Buy) 40,002 N/A N/A
Option
Common Stock 40,002 N/A N/A
Sale
Common Stock 31,489 N/A N/A
Purchase
Common Stock 4,300 N/A N/A

Neogen key executives

Neogen Corporation executives and other stock owners filed with the SEC: